胸膜间皮瘤的临床试验
总计1286个结果
-
AstraZeneca完全的
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)完全的
-
Memorial Sloan Kettering Cancer CenterUnited States Department of Defense完全的
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
Southwest Oncology GroupNational Cancer Institute (NCI)完全的
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
Cancer Trials Ireland完全的
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
Ascentage Pharma Group Inc.Suzhou Yasheng Pharmaceutical Co., Ltd.招聘中
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)招聘中
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)终止
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)未知
-
European Organisation for Research and Treatment...完全的
-
European Organisation for Research and Treatment...完全的
-
Candel Therapeutics, Inc.University of Pennsylvania完全的
-
Bayer完全的晚期复发性恶性胸膜上皮样间皮瘤 | 晚期复发性恶性腹膜上皮样间皮瘤 | 晚期复发性浆液性卵巢癌 | 晚期胰腺导管腺癌(可选,剂量扩展,未启动)美国, 瑞典, 荷兰, 英国, 芬兰
-
National Cancer Institute (NCI)招聘中间皮瘤 | BRCA1 相关蛋白 1 (BAP1) 突变 | 恶性间皮瘤 (MM) | 早期间皮瘤 | 亚临床间皮瘤 | 早期 BAP1 相关恶性肿瘤美国
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)完全的
-
Bristol-Myers Squibb招聘中
-
Arkadiusz Z. Dudek, MDBristol-Myers Squibb; Eli Lilly and Company; HealthPartners Institute Regions Cancer Care Center主动,不招人